Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 835 results for "hcv"

Novel Drug 'Sofosbuvir' Holds Promise of Treating Hepatitis C, but Cost Prohibitive
Med India

Drug holds promise of treating Hepatitis C, but cost prohibitive

A new drug has shown promise of treating the Hepatitis C virus (HCV) in India, something which had eluded health experts for long. But its widespread use may be inhibited because of its high cost - Rs.100,000 ($1,500) for the full course.Sofosbuvir has ... Prokerala, 1 day ago
FDA approves new cholesterol drug - at $14,600 a year National AIDS Treatment Advocacy Project, 18 hours ago

222 images for hcv

Pharma Letter, 3 days ago, 4 days ago, 4 days ago
MSN Entertainment, 3 days ago
European Pharmaceutical Review, 3 days ago, 3 days ago
European Pharmaceutical Review, 3 days ago
The Press NZ, 4 days ago
9ija, 5 days ago
9ija, 5 days ago

FDA accepts Merck's NDA for HCV combo grazoprevir/elbasvir

News Editor The FDA accepts for review the New Drug Application (NDA) from Merck (NYSE:MRK) for its once-daily single tablet combination of grazoprevir/elbasvir for the treatment of adult patients with chronic HCV genotypes 1, 4 or 6 infection.
 Seeking Alpha1 day ago

FIB-4, race predicts ESLD in HIV/HCV coinfected patients

The Fibrosis-4 score and race were useful in quantifying the risk for end-stage liver disease among patients with both HIV and hepatitis C virus, according to recent findings. In the retrospective cohort study, researchers evaluated 6,016 HIV/HCV ...
 Orthopedics Today1 day ago Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study  Plosone.org2 days ago Adding Ribavirin to Ledipasvir/Sofosbuvir Does Not Increase Rate of Serious Adverse Events in Patients With HCV-1 Infection: Presented at IAS  FirstWord Pharma6 days ago Ledipasvir and Sofosbuvir for HCV  New England Journal of Medicine1 week ago
European Pharmaceutical Review

Bristol-Myers Squibb's Daklinza receives US FDA approval to treat HCV genotype 3 infections

The US Food and Drug Administration approved Bristol-Myers Squibb's Daklinza (daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections. Daklinza is the first drug that has demonstrated safety and efficacy to treat ...
 PharmaBiz2 days ago Chronic HCV genotype 3 drug approved  Pharmacist.com3 days ago FDA approves Daklinza for the treatment of HCV genotype 3  European Pharmaceutical Review3 days ago FDA Oks Daklinza For Use With Sofosbuvir To Treat HCV Genotype 3 Infections  RTTNews.com6 days ago
Pharma Letter

Two New HCV Treatments Approved

—FDA approved two new oral products for the treatment of chronic hepatitis C virus (HCV) infection without the need for coadministration of an interferon, the agency announced July 24. Daclatasvir, an HCV NS5A replication complex inhibitor, is ...
 ASHP3 days ago Breakthrough Hep C Development Announced  Occupational Health & Safety2 days ago FDA Approves Daklinza for Hep C  Gastroenterology & Endoscopy News2 days ago FDA approves Daklinza for hepatitis C genotype 3  Formulary Journal2 days ago
Bidness Etc

Gilead Sciences, Inc. (GILD) HCV Prescriptions And Impact On Earnings

Gilead Sciences, Inc. ( NASDAQ:GILD ) is set to announce its earnings for the second quarter of fiscal 2015 on July 28, after the market closes. Investors wait anxiously for the earnings report, which would present a much clearer picture regarding ...
 Bidness Etc2 days ago GILD Stock: 2 Big Things You Should Know About Gilead Sciences  InvestorPlace.com1 day ago Should Gilead Really Be Rated Underperform?  24/7 Wall St1 day ago Gilead Sciences Continues To Surprise  Seeking Alpha1 day ago

Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

B ig biotech Gilead Sciences (NASDAQ: GILD ) handily beat analysts' Q2 estimates and raised its guidance Tuesday afternoon, sending its stock up in after-hours trading. Gilead's earnings, excluding one-time items, rose 33.5% over the year-earlier ...
 Investor's Business Daily2 days ago Gilead Sciences Is At It Again  Seeking Alpha1 day ago Gilead Lifts Sales View As Hep C Drugs Top  Yahoo! Singapore1 day ago Is Gilead A Buy Pre Earnings?  Seeking Alpha3 days ago

NEJM suggests use of HCV-positive kidneys as one solution to kidney shortage

 9ija News.com5 days ago Transplanting HCV-Positive Kidneys  New England Journal of Medicine1 week ago Researchers recommend use of HCV-positive organs for kidney transplant  Orthopedics Today1 week ago
Business Standard

Ashok Leyland's M&HCV June sales up by 46%

Ashok Leyland has reported a 46% growth in M&HC sales during the month of June
 Business Standard4 weeks ago Ashok Leyland gains 2.6% after announcing April sales  India Infoline2 months ago Ashok Leyland total sales in April'15 jumps 43%  India Infoline2 months ago Ashok Leyland sales up 43% in April  Business Standard2 months ago
Business Standard

M & HCV business to grow by 12 per cent

After two challenging years, medium and heavy commercial vehicle (M&HCV) industry, has bounced back to double-digit growth buoyed by economic recovery and growth centric government policies like Make in India. According to a paper released by Roland Berger ...
 Asian Age1 month ago M&HCV industry to grow 11% to 3.8 lakh units in FY20, says report  Business Standard1 month ago Tata Motors to grow CV exports  Deccan Herald1 week ago NBFCs yet to see recovery in commercial vehicle segment  The Financial Chronicle1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hcv
Get updated on latest news & your favorite topics right in your inbox!
More     Less